mr 2034 has been researched along with sufentanil in 1 studies
| Studies (mr 2034) | Trials (mr 2034) | Recent Studies (post-2010) (mr 2034) | Studies (sufentanil) | Trials (sufentanil) | Recent Studies (post-2010) (sufentanil) |
|---|---|---|---|---|---|
| 48 | 0 | 0 | 2,156 | 956 | 678 |
| Protein | Taxonomy | mr 2034 (IC50) | sufentanil (IC50) |
|---|---|---|---|
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | 4.5 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0023 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0014 | |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0023 | |
| Sigma non-opioid intracellular receptor 1 | Cavia porcellus (domestic guinea pig) | 2.077 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbott, FV; Franklin, KB; Libman, RB | 1 |
1 other study(ies) available for mr 2034 and sufentanil
| Article | Year |
|---|---|
A dose-ratio comparison of mu and kappa agonists in formalin and thermal pain.
Topics: Analgesia; Animals; Benzomorphans; Cyclazocine; Dose-Response Relationship, Drug; Ethylketocyclazocine; Fentanyl; Formaldehyde; Hot Temperature; Male; Naloxone; Pain; Rats; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu; Sufentanil | 1986 |